Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step
ConclusionTo our knowledge, this study provides the first model-informed AUC-based strategy in North American hematologic cancer patients with or without HSCT. The resulting nomogram generated provides a simplified approach to improving the accuracy of initial vancomycin dosing in this population.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Kidney Disease | Drugs & Pharmacology | Epidemiology | Hematology | Infectious Diseases | Kidney Transplant | Kidney Transplantation | MRSA | Staphylococcus Aureus | Stem Cell Therapy | Stem Cells | Study | Superbugs | Transplant Surgery | Transplants | Urology & Nephrology | USA Health